Mixed chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

被引：0
|
作者：
de Lima, M [1 ]
Carrasco, A [1 ]
Lee, MS [1 ]
Saliba, R [1 ]
Glassman, A [1 ]
Anagnostopoulos, A [1 ]
Couriel, D [1 ]
Caldera, H [1 ]
Andersson, BS [1 ]
El-Zimaity, M [1 ]
Giralt, S [1 ]
Champlin, R [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2616
引用
收藏
页码：707A / 707A
页数：1
相关论文
共 50 条
  • [1] Acute myeloid leukemia (AML) and Myelodysplastic syndrome (MDS) associated with Monosomy 7: Management by allogeneic hematopoietic stem cell transplantation (HSCT)
    Giller, RH
    Trobaugh, AD
    Hunger, SP
    Malcolm, J
    Schissel, D
    Hild, E
    Quinones, RR
    PEDIATRIC RESEARCH, 2002, 51 (04) : 251A - 251A
  • [2] Treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) relapsing after allogeneic hematopoietic cell transplantation (HCT).
    Chiattone, A.
    Andersson, B.
    Bashir, Q.
    Landau, D.
    Rondon, G.
    Nieto, Y.
    Al Atrash, G.
    Giralt, S.
    Champlin, R. E.
    De Lima, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] CD34+ lineage specific donor cell chimerism analysis for the diagnosis of minimal residual disease of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) after allogeneic hematopoietic stem cell transplantation (HSCT)
    Rosenow, F.
    Berkemeier, A.
    Silling, G.
    Berdel, W. E.
    Kienast, J.
    Stelljes, M.
    ONKOLOGIE, 2011, 34 : 229 - 229
  • [4] Evaluation of reduced intensity allogeneic hematopoietic stem cell transplantation (HSCT) using anti lymphocyte antibodies in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Popat, UR
    Carrum, G
    Krance, R
    Brenner, M
    Heslop, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 568S - 568S
  • [5] Efficacy of Lenalidomide and Bortezomib for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing after Allogeneic Stem Cell Transplantation
    Brunner, Andrew M.
    Blonquist, Traci M.
    McMasters, Malgorzata
    Hobbs, Gabriela S.
    McAfee, Steven L.
    Rosenblatt, Jacalyn
    Amrein, Philip C.
    Connolly, Christine
    Ramos, Aura Y.
    Mikami, Kaleb
    Logan, Emma
    Dey, Bimalangshu R.
    Spitzer, Thomas
    Avigan, David E.
    Chen, Yi-Bin
    Ballen, Karen K.
    El-Jawahri, Areej
    Fathi, Amir T.
    BLOOD, 2018, 132
  • [6] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Older Adults with Acute Myeloid Leukemia (AML)
    Lipof, Jodi J.
    Manogna, Dharmini
    Baran, Andrea M.
    Said, Bassil
    Becker, Michael W.
    Mendler, Jason H.
    Aljitawi, Omar S.
    O'Dwyer, Kristen Marie
    Huselton, Eric
    Burack, Richard
    Blaney, Margaret
    Douglas, Taylor
    Liesveld, Jane L.
    Loh, Kah Poh
    BLOOD, 2020, 136
  • [7] Immediate Allogeneic Hematopoietic Cell Transplantation (HCT) in Acute Myeloid Leukemia (AML) Arising From Myelodysplastic Syndrome (MDS)
    Kim, Sung-Doo
    Choi, Yunsuk
    Park, Young-Hun
    Lee, Jae Seok
    Kim, Dae-Young
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Jung, Ah Rang
    Lee, Je-Hwan
    BLOOD, 2011, 118 (21) : 888 - 889
  • [8] Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT)
    Trobaugh-Lotrario, AD
    Kletzel, M
    Quinones, RR
    McGavran, L
    Proytcheva, MA
    Hunger, SP
    Malcolm, J
    Schissel, D
    Hild, E
    Giller, RH
    BONE MARROW TRANSPLANTATION, 2005, 35 (02) : 143 - 149
  • [9] Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT)
    A D Trobaugh-Lotrario
    M Kletzel
    R R Quinones
    L McGavran
    M A Proytcheva
    S P Hunger
    J Malcolm
    D Schissel
    E Hild
    R H Giller
    Bone Marrow Transplantation, 2005, 35 : 143 - 149
  • [10] Immunological Intervention Triggered by Decreasing CD34 + Lineage-Specific Donor Cell Chimerism to Prevent Relapse of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).
    Rosenow, Felix
    Silling, Gerda
    Almut, Berkemeier
    Mueller-Tidow, Carsten
    Koschmieder, Steffen
    Bisping, Guido
    Krug, Utz
    Buechner, Thomas
    Berdel, Wolfgang E.
    Kienast, Joachim
    Stelljes, Matthias
    BLOOD, 2009, 114 (22) : 1286 - 1286
12345